Abstract:Antimicrobial peptides, such as bacteriocin, produced by probiotics have become a promising novel class of therapeutic agents for treating infectious diseases. Selected lactic acid bacteria (LAB) isolated from fermented foods with probiotic potential were evaluated for various tests, including exopolysaccharide production, antibiotic susceptibility, acid and bile tolerance, antibacterial activity, and cell adhesion and cytotoxicity to gastric cell lines. Six selected LAB strains maintained their high viability under gastrointestinal conditions, produced high exopolysaccharides, showed no or less cytotoxicity, and adhered successfully to gastric cells. Furthermore, three strains, Weissella confusa CYLB30, Lactiplantibacillus plantarum CYLB47, and Limosilactobacillus fermentum CYLB55, demonstrated a strong antibacterial effect against drug-resistant Escherichia coli, Klebsiella pneumoniae , Pseudomonas aeruginosa , Salmonella enterica serovar Choleraesuis, Enterococcus faecium , and Staphylococcus aureus. Whole genome sequencing was performed on these three strains using the Nanopore platform; then, the results showed that all three strains did not harbor genes related to toxins, superantigens, and acquired antimicrobial resistance, in their genome. The bacteriocin gene cluster was found in CYLB47 genome, but not in CYLB30 and CYLB55 genomes. In SDS-PAGE, the extract of CYLB30 and CYLB47 bacteriocin-like inhibitory substance (BLIS) yielded a single band with a size of less than 10 kDa. These BLIS inhibited the growth and biofilm formation of drug-resistant P. aeruginosa and methicillin-resistant S. aureus (MRSA), causing membrane disruption and inhibiting adhesion ability to human skin HaCaT cells. Moreover, CYLB30 and CYLB47 BLIS rescued the larvae after being infected with P. aeruginosa and MRSA infections. In conclusion, CYLB30 and CYLB47 BLIS may be potential alternative treatment for multidrug-resistant bacteria infections.

What problem does this paper attempt to address?

The problem this paper attempts to address is the issue of multi-drug resistant bacterial infections caused by antibiotic resistance (AMR). Specifically, the researchers screened lactic acid bacteria (LAB) with potential probiotic properties from fermented foods and evaluated the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substances (BLIS) produced by these strains against various clinical multi-drug resistant pathogens. Through phenotypic testing and whole-genome sequencing, the researchers aim to find novel antibacterial agents that can effectively combat multi-drug resistant bacteria. ### Research Background Antibiotic resistance (AMR) is a serious global health issue, leading to significant morbidity and high mortality rates in patients infected with multi-drug resistant bacteria. Therefore, finding new antibacterial drugs or alternative therapies to overcome AMR has become very urgent. Antimicrobial peptides (AMPs), extracted from probiotics or the human body, have become promising alternative antibacterial agents for treating multi-drug resistant bacteria and biofilm-related infections due to their effective antibacterial action and low propensity for resistance development. ### Research Objectives The objective of this study is to isolate and characterize probiotics producing bacteriocin-like inhibitory substances (BLIS) from fermented foods and to evaluate the antibacterial activity of these BLIS against clinical multi-drug resistant pathogens such as Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Salmonella Typhimurium, Enterococcus faecium, and Staphylococcus aureus. This goal is achieved through phenotypic testing and whole-genome sequencing. ### Main Findings 1. **Strain Screening and Characterization**: - 32 strains of lactic acid bacteria were screened from fermented foods purchased from traditional markets in Taiwan, of which 11 strains were identified as LAB. - 6 LAB strains (CYLB30, CYLB33, CYLB45, CYLB47, CYLB51, and CYLB55) showed high survival rates under simulated gastrointestinal conditions, produced high amounts of extracellular polysaccharides (EPS), exhibited no or low toxicity to gastric cells, and successfully adhered to gastric cells. 2. **Antibacterial Activity**: - 3 strains (CYLB30, CYLB47, and CYLB55) exhibited strong antibacterial activity against all tested multi-drug resistant pathogens. - Among them, BLIS from CYLB30 and CYLB47 showed the strongest inhibitory effect on pathogens. 3. **Genomic Analysis**: - Whole-genome sequencing using the Nanopore platform revealed that these 3 strains did not carry genes related to toxins, superantigens, or acquired antibiotic resistance. - A bacteriocin gene cluster was found in the genome of CYLB47, while no such clusters were found in the genomes of CYLB30 and CYLB55. 4. **BLIS Extraction and Activity Verification**: - BLIS extracted from CYLB30 and CYLB47 showed a single band with a molecular weight of less than 10 kDa in SDS-PAGE. - These BLIS inhibited the growth and biofilm formation of multi-drug resistant Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus (MRSA), leading to cell membrane disruption and reduced adhesion ability. 5. **Animal Experiments**: - In a wax moth larva infection model, BLIS from CYLB30 and CYLB47 significantly increased the survival rate of larvae infected with Pseudomonas aeruginosa and MRSA. ### Conclusion BLIS from CYLB30 and CYLB47 may become potential alternative therapies for treating multi-drug resistant bacterial infections. These BLIS not only exhibit broad-spectrum antibacterial activity against various clinical multi-drug resistant pathogens but also demonstrate good safety in both in vitro and in vivo experiments.

Characterization of the broad-spectrum antibacterial activity of bacteriocin-like inhibitory substance-producing probiotics isolated from fermented foods

Genetic and phenotypic assessment of the antimicrobial activity of three potential probiotic lactobacilli against human enteropathogenic bacteria

Bioinformatics analysis of purified and identified novel bacteriocin‐like inhibitory substances produced by Streptomyces sp.

Bacteriocin producing microbes with bactericidal activity against multidrug resistant pathogens

Suppressive effects of Streptococcus thermophilus KLDS 3.1003 on some foodborne pathogens revealed through in vitro, in vivo and genomic insights

Safety and Beneficial Properties of Bacteriocinogenic Lactococcus lactis and Pediococcus pentosaceus Strains, and Their Effect Versus Oral Cavity Related and Antibiotic-Resistant Pathogens

Characterisation of Bacteriocins Produced by Lactobacillus spp. Isolated from the Traditional Pakistani Yoghurt and Their Antimicrobial Activity against Common Foodborne Pathogens

Screening and Identification of Goat-Milk-Derived Lactic Acid Bacteria with Bacteriocin-like Activity and Probiotic Potentials

Evaluation of inhibitory and probiotic properties of lactic acid bacteria isolated from vaginal microflora

A comparison of mining methods to extract novel bacteriocins from Lactiplantibacillus plantarum NWAFU-BIO-BS29

Bacteriocin and Antioxidant Production, a Beneficial Properties of Lactic Acid Bacteria Isolated from Fermented Vegetables of Northwest Bulgaria

Bacteriocin Harvested from the Synbiotic Culture of Selected Lactic Acid Bacteria with Various Vegetables, Cereals, Fruits, Medicinal and Tuber Plants: Inhibition of Vibrio parahaemolyticus

Isolation and characterization of lactobacilli from some traditional fermented foods and evaluation of the bacteriocins

Evaluation of antimicrobial effect of bacteriocin produced by Lactobacillus acidophilus utilizing molasses and corn steep liquor

Lactic acid bacteria isolated from Chinese traditional fermented milk as novel probiotic strains and their potential therapeutic applications

Cultivation of Lactic Acid Bacteria and Evaluation of the Antimicrobial Potential of Partially Purified Bacteriocin-like Inhibitory Substances against Cariogenic and Food Pathogens

In Vitro Evaluation of Probiotic Properties and Anti-Pathogenic Effects of Lactobacillus and Bifidobacterium Strains as Potential Probiotics

Probiotic cell-free supernatant as effective antimicrobials against Klebsiella pneumoniae and reduce antibiotic resistance development

Purification and characterization of bacteriocin produced by a strain of Lacticaseibacillus rhamnosus ZFM216

Purification and Characterization of Bacteriocin Produced by Weissella confusa A3 of Dairy Origin

Lactic acid bacterial bacteriocins and their bioactive properties against food-associated antibiotic-resistant bacteria